Bavarian Nordic could be first on the RSV market in China

A new partnership deal with Nuance Pharma turns Bavarian Nordic’s sights to China. CFO Henrik Juuel opens up about the chance for Bavarian Nordic to be first on the market – a very lucrative position for the firm.
Henrik Juuel, CFO at Bavarian Nordic | Photo: Bavarian Nordic PR
Henrik Juuel, CFO at Bavarian Nordic | Photo: Bavarian Nordic PR
by CHRISTIAN BUNDGAARD, translated by daniel pedersen

The race to the RSV market is fully underway, and on Monday, Bavarian Nordic began sprinting – at least in the direction of the Chinese market.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading